| 摘要 |
The present invention is directed to a pharmaceutical composition for the treatment of diseases having an etiology based on or accompanied by excess male hormone. The pharmaceutical composition comprises a cyclodextrin or derivative thereof in association with a pharmaceutically acceptable carrier, diluent or excipient.
|
